Results

Total Results: 1,252 records

Showing results for "developed".

1241. Aspirin for the Primary Prevention of Cardiovascular Events: An Update of the Evidence (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/t6yV6ZMHngeWgmTsoMMefM
      March 01, 2009 - ANALYTIC FRAMEWORK AND KEY QUESTIONS In consultation with the USPSTF, we developed an analytic framework … From this analytic frame- work, we developed the following key questions (KQs): KQ1a.

1242. Archived: Drug Abuse: Screening, 1996 | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-abuse-screening-1996
      January 01, 1996 - in drug-dependent patients (see below), they have largely been studied in patients who have already developed … A treatment plan should be developed for the patient and family that is tailored to the drug of abuse

1243. Screening for Autism Spectrum Disorder in Young Children: USPSTF Recommendation Statement (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/Lm94jySKCYrG3zsUP8Jd8E
      February 16, 2016 - Other professional and advocacy organizations have also developed toolkits and resources. … identified through case-finding and were older than the age group for which the screen- ing tools were developed

1244. Archived: Falls Prevention in Older Adults: Counseling and Preventive Medication | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/recommendation/falls-prevention-in-older-adults-counseling-and-preventive-medication-2012
      May 15, 2012 - Since the 1996 recommendation, the USPSTF has developed and adapted its methods, the framework for systematic … Several tools have been developed that use combinations of risk factors to predict falls.

1245. Archived: Final Evidence Summary: Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: Preventive Medication | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary51/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication-september-2014
      April 08, 2014 - based MFMU (Maternal-Fetal Medicine Units) trial instructed women to stop treatment if preeclampsia developed … Preterm birth is the cause of 70% of neonatal mortality and 75% of neonatal morbidity in developed countries

1246. Procedure Manual Appendix X. Factors to Consider When Recommending Screening Intervals | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-x-factors-consider-when-recommending-screening-intervals
      July 01, 2017 - Procedure Manual Appendix X. Factors to Consider When Recommending Screening Intervals Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence regarding the following factors should be considered when recommending a scree…

1247. High-Priority Evidence Gaps For Clinical Preventive Services: 7th Annual Report to Congress (pdf file)
      www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annual-report-to-congress-2017%20(2).pdf
      January 01, 2017 - These organizations and agencies provide input on the recommendations as they are being developed and

1248. High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress (pdf file)
      www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(9).pdf
      November 01, 2014 - High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress HIGH-PRIORITY EVIDENCE GAPS FOR CLINICAL PREVENTIVE SERVICES Fourth Annual REPORT TO CONGRESS November 2014 SUBMITTED BY: Dr. Michael LeFevre, Chair Dr. Kirsten Bibbins-Domingo, Vice Chair Dr. Albert Siu, Vice Chair ON …

1249. High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress (pdf file)
      www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(6).pdf
      November 01, 2014 - High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress HIGH-PRIORITY EVIDENCE GAPS FOR CLINICAL PREVENTIVE SERVICES Fourth Annual REPORT TO CONGRESS November 2014 SUBMITTED BY: Dr. Michael LeFevre, Chair Dr. Kirsten Bibbins-Domingo, Vice Chair Dr. Albert Siu, Vice Chair ON …

1250. Cancer Older Adults (pdf file)
      www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/cancer_older_adults.pdf
      September 28, 2012 - support cancer screening.38 To improve patient understanding of screening value, decision aids have been developed … Mathieu and colleagues developed a decision aid outlining potential risks of breast cancer screening,

1251. Task Forces Issues Draft Recommendation Statement on Folic Acid Supplementation to Prevent Neural Tube Defects (pdf file)
      www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/folic-acid-suppl-draft-rec-bulletin.pdf
      March 20, 2023 - Task Forces Issues Draft Recommendation Statement on Folic Acid Supplementation to Prevent Neural Tube Defects www.uspreventiveservicestaskforce.org 1 Task Force Issues Draft Recommendation Statement on Folic Acid Supplementation to Prevent Neural Tube Defects Taking folic acid before and during early…

1252. Screening for Syphilis: A Brief Update (pdf file)
      www.uspreventiveservicestaskforce.org/USPSTF_Admin/Home/GetFile/1/996/syphilup/pdf
      July 01, 2004 - with a group given a single benzathine penicillin G injection.31 None of the patients in either group developed … New tests are being developed, particularly those related to on-site testing or improved testing in newborns